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Lamotte M1, Annemans L1, Evers T2, Kubin M3
1HEDM, Meise, Belgium; 2Bayer Vital GmbH, Leverkusen, Germany;
3Bayer HealthCare, Wuppertal, Elberfeld, Germany
OBJECTIVES: Low-dose Aspirin is standard care in patients
with a history of cardiovascular disease (CVD). In primary pre-
vention the use of low-dose Aspirin is not yet fully established
although meta-analyses and US and European guidelines support
its use in persons at increased CVD risk. This study assessed the
health economic consequences of the use of low-dose Aspirin in
the primary prevention of CVD in the UK. METHODS: Based
on results (beneﬁts and harms) reported in the meta-analyses of
Hayden (2002) and Eidelman (2003), a Markov model was
developed to predict the cost-effectiveness of low-dose Aspirin
in the primary prevention of CVD. The model consists of 5
health states: no history of CVD, history of stroke, history of
myocardial infarction, history of CVD and death. A 10-year time
horizon and 1-year cycles were used. Secondary prevention data
were derived from the Aspirin group of the CAPRIE-study
(1996). Direct costs from the NHS (2003) perspective were used.
Effects were expressed in Life-Years Gained (LYG) and Quality-
Adjusted-Life-Years Gained (QALY). Utility data (TTO) were
obtained from published data. Discounting was applied (3.5%
on effects and costs). RESULTS: For patients with a 10-year risk
of coronary heart disease (CHD) of 15% the model results in a
10-year cost of £899 ± 44 (1360 ± 64€) without and £767 ± 53
(1163 ± 81€) with Aspirin. Low-dose Aspirin treatment saves on
average £115 per patient. LYG were respectively 8.17 ± 0.01 and
8.19 ± 0.02, QALYG 8.04 ± 0.02 and 8.08 ± 0.03. Monte Carlo
analysis showed Aspirin-dominance in 96.7% of cases. Savings
start in the ﬁrst year. Treating all UK individuals with a risk
≥15% would result in at least £1.5 billion of savings over 10
years. CONCLUSIONS: Administering low-dose Aspirin to
patients with a 10-year risk of CHD of 15% and more is sig-
niﬁcantly cost-saving from the NHS perspective. Sensitivity
analyses (CHD risk and bleedings) proved robustness of the
results.
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OBJECTIVES: This study investigated the association between
LDL-cholesterol goal attainment (LDL-C < 130mg/dL in
national guidelines) during three consecutive years and occur-
rence of cardiovascular events (CV) in multiple CV risk factor
(>3) patients without coronary heart disease history in French
primary care. METHODS: A total of 579 patients treated with
lipid lowering drugs (LLD) for 3 years (2000–2002) and with a
yearly documented LDL-C were included by 236 primary care
physicians. Patients were classiﬁed into three groups according
to the number of consecutive years they attained TO: all three
years (TO+++: n = 145), only part of the time (TO intermediate:
n = 256), and never (TO—: n = 178). CV risk factors and CV
events (angina pectoris, myocardial infarction, heart failure,
stroke, peripheral artery disease) occurring during the last year
of observation (2002) were retrospectively collected through
computerized medical records (Thales database) and a speciﬁc
physician questionnaire. The risk of occurrence of CV events was
studied according to TO status. Logistic regression model was
used, to adjust for baseline differences in CV risk factors.
RESULTS: Only 25% of patients reached TO during all three
years. Patients with at least one CV event were 5.5%, 10.5%
and 12.9% respectively in the TO+++, TO intermediate and
TO— groups. Compared to TO+++, signiﬁcantly increased risk
of CV event was observed, both for TO intermediate (OR = 2.34,
95% IC = [1.01; 5.39]) and TO— groups (OR = 2.99, 95% 
CI = [1.26; 7.08]). The trend in CV risk between the three TO
groups signiﬁcantly increased (p = 0.02). CONCLUSIONS: This
study conﬁrms that inadequate LDL-cholesterol goal attainment
in high CV risk patients treated with LLD is associated with an
increased risk of cardiovascular morbidity. Our results strongly
support the necessity of a better adherence to guidelines to
improve cardiovascular prevention.
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NURSING HOME RESIDENTS WITH STROKE: CHANGES IN
MANAGEMENT LEVELS AND COSTS OVER A SIX YEAR
PERIOD
O’Brien JA, Duran P, Caro JJ
Caro Research Institute, Concord, MA, USA
OBJECTIVE: To identify changes in management levels and
costs for a cohort of nursing home residents admitted for
ischemic stroke over a 6-year period. METHODS: Data from 
Minnesota’s long-term care databases for 1995 through 2000
were examined. Nurses from Minnesota’s Quality Assurance and
Review Program evaluate care needs of each nursing home resi-
dent annually. Residents are classiﬁed according to dependence
level in each of eight activities of daily living (ADL). Residents
dependent in 0–3 ADLs are assigned to the low, 4–6 to the
medium, or 7–8 to the high dependency category. This ADL
assessment and other factors establish the management level and
reimbursement rate for care. Stroke cases were identiﬁed using
ICD-9 principal diagnosis codes and personal identiﬁers. Only
stroke patients who were residents throughout the six years were
included in this analysis. Nursing home reimbursement rates for
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